What is Radioimmunoassay Market?
Radioimmunoassay (RIA) is a sensitive and quantitative method used to detect and quantitate the number of antigens in vitro. It is a very important tool in clinical practice and biomedical research. Radioimmunoassay commonly used to assay microbial antigens, vitamins, proteins, hormones, or drugs in serum. The factors such as Increased Prevalence of Cancer and Infectious Diseases and Increased Research and Development Activities are the key factors driving the global Radioimmunoassay market. In addition, Technological Advancement in the Healthcare Sector also fueling market growth. However, the High Cost of Equipment may hamper the market growth.
The market study is being classified by Type (Reagents & Kits and Analyzers), by Application (Research, Clinical Diagnostics and Others) and major geographies with country level break-up.
PerkinElmer, Inc. (United States), DRG International, Inc. (United States), DIAsource ImmunoAssays SA (Belgium), Beckman Coulter, Inc. (United States), IBL International (A Tecan Company) (Germany), MP Biomedicals, LLC (United States), Cisbio (France), Euro Diagnostica AB (Sweden), DiaSorin S.p.A. (Italy), EMD Millipore (United States), Izotop (Hungary), Berthold Technologies GmbH & Co. KG (Germany) and Stratec Biomedical AG (Germany) are some of the key players profiled in the study.
The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Radioimmunoassay market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Radioimmunoassay market by Type, Application and Region.
On the basis of geography, the market of Radioimmunoassay has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increased Prevalence of Cancer and Infectious Diseases
- Increased Research and Development Activities
- Technological Advancement in the Healthcare Sector
- High Cost of the Equipment
- Growth in the Healthcare Industry Worldwide
- Increasing Demand for Healthcare Automation
- Stringent Government Rules and Regulations
Key Target AudienceRadioimmunoassay Equipment Manufacturers, Raw Material Suppliers, Distributors, Emerging Companies, Research Professionals and End-users
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase